Protein tyrosine kinase 6 directly phosphorylates AKT and promotes AKT activation in response to epidermal growth factor

Molecular and Cellular Biology

Volumn 30, Issue 17, 2010, Pages 4280-4292

  Zheng, Yu ^a   Peng, Maoyu ^a   Wang, Zebin ^a   Asara, John M ^b   Tyner, Angela L ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; PROTEIN KINASE B; PROTEIN KINASE FYN; PROTEIN KINASE YES; PROTEIN SH2; PROTEIN SH3; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE 6; UNCLASSIFIED DRUG; CARRIER PROTEIN; PTK6 PROTEIN, HUMAN; PTK9L PROTEIN, MOUSE; TUMOR PROTEIN; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; EMBRYO CELL; ENZYME SUBSTRATE; EPITHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SRC HOMOLOGY DOMAIN; ANIMAL; CELL LINE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHOSPHORYLATION; TUMOR CELL LINE;

ANIMALS; CARRIER PROTEINS; CELL LINE; CELL LINE, TUMOR; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION; HUMANS; MICE; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SRC HOMOLOGY DOMAINS; SRC-FAMILY KINASES; TYROSINE;

EID: 77956620778     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00024-10     Document Type: Article

References (55)

1. Alessi, D. R., M. Andjelkovic, B. Caudwell, P. Cron, N. Morrice, P. Cohen, and B. A. Hemmings. 1996. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15:6541-6551.
2. Altomare, D. A., H. You, G. H. Xiao, M. E. Ramos-Nino, K. L. Skele, A. De Rienzo, S. C. Jhanwar, B. T. Mossman, A. B. Kane, and J. R. Testa. 2005. Human and mouse mesotheliomas exhibit elevated AKT/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growth. Oncogene 24:6080-6089.
3. Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.
4. Aubele, M., G. Auer, A. K. Walch, A. Munro, M. J. Atkinson, H. Braselmann, T. Fornander, and J. M. Bartlett. 2007. PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas. Br. J. Cancer 96:801-807.
5. Aubele, M., A. K. Walch, N. Ludyga, H. Braselmann, M. J. Atkinson, B. Luber, G. Auer, S. Tapio, T. Cooke, and J. M. Bartlett. 2008. Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients. Br. J. Cancer 99:1089-1095.
6. Barker, K. T., L. E. Jackson, and M. R. Crompton. 1997. BRK tyrosine kinase expression in a high proportion of human breast carcinomas. Oncogene 15:799-805.
7. Bellacosa, A., C. C. Kumar, A. Di Cristofano, and J. R. Testa. 2005. Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv. Cancer Res. 94:29-86.
8. Born, M., L. Quintanilla-Fend, H. Braselmann, U. Reich, M. Richter, P. Hutzler, and M. Aubele. 2005. Simultaneous over-expression of the Her2/neu and PTK6 tyrosine kinases in archival invasive ductal breast carcinomas. J. Pathol. 205:592-596.
9. Brauer, P. M., and A. L. Tyner. 2010. Building a better understanding of the intracellular tyrosine kinase PTK6 - BRK by BRK. Biochim. Biophys. Acta 1806:66-73.
10. Chen, H. Y., C. H. Shen, Y. T. Tsai, F. C. Lin, Y. P. Huang, and R. H. Chen. 2004. Brk activates Rac1 and promotes cell migration and invasion by phosphorylating paxillin. Mol. Cell. Biol. 24:10558-10572.
11. Chen, R., O. Kim, J. Yang, K. Sato, K. M. Eisenmann, J. McCarthy, H. Chen, and Y. Qiu. 2001. Regulation of Akt/PKB activation by tyrosine phosphorylation. J. Biol. Chem. 276:31858-31862.
12. Conus, N. M., K. M. Hannan, B. E. Cristiano, B. A. Hemmings, and R. B. Pearson. 2002. Direct identification of tyrosine 474 as a regulatory phosphorylation site for the Akt protein kinase. J. Biol. Chem. 277:38021-38028.
13. Cui, Q. L., W. H. Zheng, R. Quirion, and G. Almazan. 2005. Inhibition of Src-like kinases reveals Akt-dependent and -independent pathways in insulin-like growth factor I-mediated oligodendrocyte progenitor survival. J. Biol. Chem. 280:8918-8928.
14. Derry, J. J., G. S. Prins, V. Ray, and A. L. Tyner. 2003. Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells. Oncogene 22:4212-4220.
15. Derry, J. J., S. Richard, H. Valderrama Carvajal, X. Ye, V. Vasioukhin, A. W. Cochrane, T. Chen, and A. L. Tyner. 2000. Sik (BRK) phosphorylates Sam68 in the nucleus and negatively regulates its RNA binding ability. Mol. Cell. Biol. 20:6114-6126.
16. Easty, D. J., P. J. Mitchell, K. Patel, V. A. Florenes, R. A. Spritz, and D. C. Bennett. 1997. Loss of expression of receptor tyrosine kinase family genes PTK7 and SEK in metastatic melanoma. Int. J. Cancer 71:1061-1065.
17. El Sheikh, S. S., J. Domin, P. Abel, G. Stamp, and E.-N. Lalani. 2004. Phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGF. Neoplasia 6:846-853.
18. Eves, E. M., W. Xiong, A. Bellacosa, S. G. Kennedy, P. N. Tsichlis, M. R. Rosner, and N. Hay. 1998. Akt, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line. Mol. Cell. Biol. 18:2143-2152.
19. Gingras, A. C., S. G. Kennedy, M. A. O'Leary, N. Sonenberg, and N. Hay. 1998. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev. 12:502-513.
20. Haegebarth, A., W. Bie, R. Yang, S. E. Crawford, V. Vasioukhin, E. Fuchs, and A. L. Tyner. 2006. Protein tyrosine kinase 6 negatively regulates growth and promotes enterocyte differentiation in the small intestine. Mol. Cell. Biol. 26:4949-4957.
21. Haegebarth, A., A. O. Perekatt, W. Bie, J. J. Gierut, and A. L. Tyner. 2009. Induction of protein tyrosine kinase 6 in mouse intestinal crypt epithelial cells promotes DNA damage-induced apoptosis. Gastroenterology 137:945-954.
22. Harvey, A. J., and M. R. Crompton. 2003. Use of RNA interference to validate Brk as a novel therapeutic target in breast cancer: Brk promotes breast carcinoma cell proliferation. Oncogene 22:5006-5010.
23. Hayward, S. W., R. Dahiya, G. R. Cunha, J. Bartek, N. Deshpande, and P. Narayan. 1995. Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In Vitro Cell. Dev. Biol. Anim. 31:14-24.
24. Hong, E., J. Shin, H. I. Kim, S. T. Lee, and W. Lee. 2004. Solution structure and backbone dynamics of the non-receptor protein-tyrosine kinase-6 Src homology 2 domain. J. Biol. Chem. 279:29700-29708.
25. Ie Kim, H., and S. T. Lee. 2009. Oncogenic functions of PTK6 are enhanced by its targeting to plasma membrane but abolished by its targeting to nucleus. J. Biochem. 146:133-139.
26. Jacinto, E., V. Facchinetti, D. Liu, N. Soto, S. Wei, S. Y. Jung, Q. Huang, J. Qin, and B. Su. 2006. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127:125-137.
27. Jiang, T., and Y. Qiu. 2003. Interaction between Src and a C-terminal proline-rich motif of Akt is required for Akt activation. J. Biol. Chem. 278:15789-15793.
28. Jung, H. S., D. W. Kim, Y. S. Jo, H. K. Chung, J. H. Song, J. S. Park, K. C. Park, S. H. Park, J. H. Hwang, K. W. Jo, and M. Shong. 2005. Regulation of protein kinase B tyrosine phosphorylation by thyroid-specific oncogenic RET/PTC kinases. Mol. Endocrinol. 19:2748-2759.
29. Kamalati, T., H. E. Jolin, M. J. Fry, and M. R. Crompton. 2000. Expression of the BRK tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylation. Oncogene 19:5471-5476.
30. Kamalati, T., H. E. Jolin, P. J. Mitchell, K. T. Barker, L. E. Jackson, C. J. Dean, M. J. Page, B. A. Gusterson, and M. R. Crompton. 1996. Brk, a breast tumor-derived non-receptor protein-tyrosine kinase, sensitizes mammary epithelial cells to epidermal growth factor. J. Biol. Chem. 271:30956-30963.
31. Klinghoffer, R. A., C. Sachsenmaier, J. A. Cooper, and P. Soriano. 1999. Src family kinases are required for integrin but not PDGFR signal transduction. EMBO J. 18:2459-2471.
32. Lee, S. T., K. M. Strunk, and R. A. Spritz. 1993. A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes. Oncogene 8:3403-3410.
33. Lin, H. S., G. J. Berry, W. E. Fee, Jr., D. J. Terris, and Z. Sun. 2004. Identification of tyrosine kinases overexpressed in head and neck cancer. Arch. Otolaryngol. Head Neck Surg. 130:311-316.
34. Llor, X., M. S. Serfas, W. Bie, V. Vasioukhin, M. Polonskaia, J. Derry, C. M. Abbott, and A. L. Tyner. 1999. BRK/Sik expression in the gastrointestinal tract and in colon tumors. Clin. Cancer Res. 5:1767-1777.
35. Lodeiro, M., M. Theodoropoulou, M. Pardo, F. F. Casanueva, and J. P. Camina. 2009. c-Src regulates Akt signaling in response to ghrelin via beta-arrestin signaling-independent and -dependent mechanisms. PLoS One 4:e4686.
36. Lukong, K. E., D. Larocque, A. L. Tyner, and S. Richard. 2005. Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression. J. Biol. Chem. 280:38639-38647.
37. Mahajan, K., D. Coppola, S. Challa, B. Fang, Y. A. Chen, W. Zhu, A. S. Lopez, J. Koomen, R. W. Engelman, C. Rivera, R. S. Muraoka-Cook, J. Q. Cheng, E. Schonbrunn, S. M. Sebti, H. S. Earp, and N. P. Mahajan. 2010. Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation. PLoS One 5:e9646.
38. Manning, B. D., and L. C. Cantley. 2007. AKT/PKB signaling: navigating downstream. Cell 129:1261-1274.
39. Mitchell, P. J., K. T. Barker, J. E. Martindale, T. Kamalati, P. N. Lowe, M. J. Page, B. A. Gusterson, and M. R. Crompton. 1994. Cloning and characterisation of cDNAs encoding a novel non-receptor tyrosine kinase, brk, expressed in human breast tumours. Oncogene 9:2383-2390.
40. Ostrander, J. H., A. R. Daniel, K. Lofgren, C. G. Kleer, and C. A. Lange. 2007. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells. Cancer Res. 67:4199-4209.
41. Palka-Hamblin, H. L., J. J. Gierut, W. Bie, P. M. Brauer, Y. Zheng, J. M. Asara, and A. L. Tyner. 2010. Identification of β-catenin as a target of the intracellular tyrosine kinase PTK6. J. Cell Sci. 23:236-245.
42. Petro, B. J., R. C. Tan, A. L. Tyner, M. W. Lingen, and K. Watanabe. 2004. Differential expression of the non-receptor tyrosine kinase BRK in oral squamous cell carcinoma and normal oral epithelium. Oral Oncol. 40:1040-1047.
43. Qiu, H., and W. T. Miller. 2002. Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition. J. Biol. Chem. 277:34634-34641.
44. Qiu, H., and W. T. Miller. 2004. Role of the Brk SH3 domain in substrate recognition. Oncogene 23:2216-2223.
45. Robey, R. B., and N. Hay. 2009. Is Akt the "Warburg kinase"? - Akt-energy metabolism interactions and oncogenesis. Semin. Cancer Biol. 19:25-31.
46. Sarbassov, D. D., D. A. Guertin, S. M. Ali, and D. M. Sabatini. 2005. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307:1098-1101.
47. Schmandt, R. E., M. Bennett, S. Clifford, A. Thornton, F. Jiang, R. R. Broaddus, C. C. Sun, K. H. Lu, A. K. Sood, and D. M. Gershenson. 2006. The BRK tyrosine kinase is expressed in high-grade serous carcinoma of the ovary. Cancer Biol. Ther. 5:1136-1141.
48. Serfas, M. S., and A. L. Tyner. 2003. Brk, Srm, Frk, and Src42A form a distinct family of intracellular Src-like tyrosine kinases. Oncol. Res. 13:409-419.
49. Shen, C. H., H. Y. Chen, M. S. Lin, F. Y. Li, C. C. Chang, M. L. Kuo, J. Settleman, and R. H. Chen. 2008. Breast tumor kinase phosphorylates p190RhoGAP to regulate rho and ras and promote breast carcinoma growth, migration, and invasion. Cancer Res. 68:7779-7787.
50. Siyanova, E. Y., M. S. Serfas, I. A. Mazo, and A. L. Tyner. 1994. Tyrosine kinase gene expression in the mouse small intestine. Oncogene 9:2053-2057.
51. Vasioukhin, V., M. S. Serfas, E. Y. Siyanova, M. Polonskaia, V. J. Costigan, B. Liu, A. Thomason, and A. L. Tyner. 1995. A novel intracellular epithelial cell tyrosine kinase is expressed in the skin and gastrointestinal tract. Oncogene 10:349-357.
52. Vasioukhin, V., and A. L. Tyner. 1997. A role for the epithelial-cell-specific tyrosine kinase Sik during keratinocyte differentiation. Proc. Natl. Acad. Sci. U. S. A. 94:14477-14482.
53. Wang, T. C., S. H. Jee, T. F. Tsai, Y. L. Huang, W. L. Tsai, and R. H. Chen. 2005. Role of breast tumour kinase in the in vitro differentiation of HaCaT cells. Br. J. Dermatol. 153:282-289.
54. Xiang, B., K. Chatti, H. Qiu, B. Lakshmi, A. Krasnitz, J. Hicks, M. Yu, W. T. Miller, and S. K. Muthuswamy. 2008. Brk is coamplified with ErbB2 to promote proliferation in breast cancer. Proc. Natl. Acad. Sci. U. S. A. 105:12463-12468.
55. Zhang, P., J. H. Ostrander, E. J. Faivre, A. Olsen, D. Fitzsimmons, and C. A. Lange. 2005. Regulated association of protein kinase B/Akt with breast tumor kinase. J. Biol. Chem. 280:1982-1991.